Phase I and pharmacokinetic evaluation of the anti-telomerase agent KML-001 with cisplatin in advanced solid tumors.

Edelman, Martin J

Phase I and pharmacokinetic evaluation of the anti-telomerase agent KML-001 with cisplatin in advanced solid tumors. [electronic resource] - Cancer chemotherapy and pharmacology Nov 2016 - 959-967 p. digital

Publication Type: Clinical Trial, Phase I; Journal Article

1432-0843

10.1007/s00280-016-3148-x doi


Aged
Antineoplastic Agents--administration & dosage
Antineoplastic Combined Chemotherapy Protocols--adverse effects
Arsenic--blood
Arsenites--administration & dosage
Cisplatin--administration & dosage
Endpoint Determination
Enzyme Inhibitors--administration & dosage
Female
Humans
Long QT Syndrome--chemically induced
Male
Middle Aged
Neoplasms--drug therapy
Platinum--blood
Sodium Compounds--administration & dosage
Telomerase--antagonists & inhibitors
Treatment Outcome